HELEN TYSON: Open Payments
NPI 1891437463 · KELLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 55 payments from 17 companies in 2025. Trend: 2023 $1,259 · 2024 $1,241 · 2025 $954
Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $168 |
| PFIZER INC. | 11 | $160 |
| AstraZeneca Pharmaceuticals LP | 3 | $142 |
| Novo Nordisk Inc | 10 | $140 |
| Janssen Pharmaceuticals, Inc | 3 | $51 |
| Astellas Pharma US Inc | 2 | $38 |
| Exact Sciences Corporation | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $25 |
Products named: MOUNJARO, FARXIGA, Rybelsus, ELIQUIS, PREVNAR 20, JARDIANCE, SPRAVATO, ABRYSVO.
Industry payments across TX — which companies pay providers there.
